Grignaschi, Silvia
Kim, Minchul http://orcid.org/0000-0001-9737-6255
Zanframundo, Giovanni
Ravichandran, Naveen http://orcid.org/0000-0003-2014-3925
Lilleker, James B. http://orcid.org/0000-0002-9230-4137
Sen, Parikshit http://orcid.org/0000-0002-1630-6026
Joshi, Mrudula http://orcid.org/0000-0001-7312-351X
Agarwal, Vishwesh http://orcid.org/0000-0002-0986-8354
Kardes, Sinan http://orcid.org/0000-0002-6311-8634
Day, Jessica http://orcid.org/0000-0001-8528-4361
Makol, Ashima http://orcid.org/0000-0002-8748-898X
Milchert, Marcin http://orcid.org/0000-0002-0943-8768
Gheita, Tamer http://orcid.org/0000-0002-1155-9729
Salim, Babur http://orcid.org/0000-0001-8430-9299
Velikova, Tsvetelina http://orcid.org/0000-0002-0593-1272
Gracia-Ramos, Abraham Edgar http://orcid.org/0000-0003-1842-2554
Parodis, Ioannis http://orcid.org/0000-0002-4875-5395
Nikiphorou, Elena http://orcid.org/0000-0001-6847-3726
Chatterjee, Tulika http://orcid.org/0000-0001-8844-851X
Tan, Ai Lyn http://orcid.org/0000-0002-9158-7243
Saavedra, Miguel A. http://orcid.org/0000-0003-0687-9944
Shinjo, Samuel Katsuyuki http://orcid.org/0000-0002-3682-4517
Ziade, Nelly http://orcid.org/0000-0002-4479-7678
Knitza, Johannes http://orcid.org/0000-0001-9695-0657
Kuwana, Masataka http://orcid.org/0000-0001-8352-6136
Nune, Arvind http://orcid.org/0000-0002-3849-614X
Distler, Oliver http://orcid.org/0000-0002-0546-8310
Chinoy, Hector http://orcid.org/0000-0001-6492-1288
Cavagna, Lorenzo http://orcid.org/0000-0003-3292-1528
Agarwal, Vikas http://orcid.org/0000-0002-4508-1233
Aggarwal, Rohit http://orcid.org/0000-0001-7531-8038
Gupta, Latika http://orcid.org/0000-0003-2753-2990
Barman, Bhupen
Singh, Yogesh Preet
Ranjan, Rajiv
Jain, Avinash
Pandya, Sapan C
Pilania, Rakesh Kumar
Sharma, Aman
Manoj, M Manesh
Gupta, Vikas
Kavadichanda, Chengappa G
Patro, Pradeepta Sekhar
Ajmani, Sajal
Phatak, Sanat
Goswami, Rudra Prosad
Chowdhury, Abhra Chandra
Mathew, Ashish Jacob
Shenoy, Padnamabha
Asranna, Ajay
Bommakanti, Keerthi Talari
Shukla, Anuj
Pande, Arunkumar R
Chandwar, Kunal
Cansu, Döndü Üsküdar
Pauling, John D
Wincup, Chris
Papa, Nicoletta Del
Sambataro, Gianluca
Fabiola, Atzeni
Govoni, Marcello
Parisi, Simone
Bocci, Elena Bartoloni
Sebastiani, Gian Domenico
Fusaro, Enrico
Sebastiani, Marco
Quartuccio, Luca
Franceschini, Franco
Sainaghi, Pier Paolo
Orsolini, Giovanni
De Angelis, Rossella
Danielli, Maria Giovanna
Venerito, Vincenzo
Traboco, Lisa S
Wibowo, Suryo Anggoro Kusumo
Serrano, Jorge Rojas
Torre, Ignacio García-De La
Tehozol, Erick Adrian Zamora
Loarce-Martos, Jesús
Prieto-González, Sergio
Gonzalez, Raquel Aranega
Yoshida, Akira
Nakashima, Ran
Sato, Shinji
Kimura, Naoki
Kaneko, Yuko
Tomaras, Stylianos
Gromova, Margarita Aleksandrovna
Aharonov, Or
Hmamouchi, Ihsane
Hoff, Leonardo Santos
Giannini, Margherita
Maurier, François
Campagne, Julien
Meyer, Alain
Nagy-Vincze, Melinda
Langguth, Daman
Limaye, Vidya
Needham, Merrilee
Srivastav, Nilesh
Hudson, Marie
Landon-Cardinal, Océane
Shaharir, Syahrul Sazliyana
Zuleta, Wilmer Gerardo Rojas
Silva, José António Pereira
Fonseca, João Eurico
,
Article History
Received: 9 April 2023
Accepted: 6 May 2023
First Online: 14 June 2023
Declarations
:
: ALT has received honoraria for advisory boards and speaking for Abbvie, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB. EN has received speaker honoraria/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly, and holds research grants from Pfizer and Lilly. HC has received grant support from Eli Lilly and UCB, consulting fees from Novartis, Eli Lilly, Orphazyme, Astra Zeneca, speaker for UCB, and Biogen. IP has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis and F. Hoffmann-La Roche AG. JBL has received speaker honoraria/participated in advisory boards for Sanofi Genzyme, Roche, and Biogen. None is related to this manuscript. JD has received research funding from CSL Limited. NZ has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript. MK has received speaker honoraria/participated in advisory boards for Abbvie, Asahi-Kasei, Astellas, AstraZeneca, Boehringer-Ingelheim, Chugai, Corbus, Eisai, GSK, Horizon, Kissei, BML, Mochida, Nippon Shinyaku, Ono Pharmaceuticals, Tanabe-Mitsubishi. TV has received speaker honoraria from Pfizer and AstraZeneca, non-related to the current manuscript. OD has/had consultancy relationship with and/or has received research funding from and/or has served as a speaker for the following companies in the area of potential treatments for systemic sclerosis and its complications in the last three calendar years: 4P-Pharma, Abbvie, Acceleron, Alcimed, Altavant, Amgen, AnaMar, Arxx, AstraZeneca, Baecon, Blade, Bayer, Boehringer Ingelheim, Corbus, CSL Behring, Galderma, Galapagos, Glenmark, Gossamer, iQvia, Horizon, Inventiva, Janssen, Kymera, Lupin, Medscape, Merck, Miltenyi Biotec, Mitsubishi Tanabe, Novartis, Prometheus, Redxpharma, Roivant, Sanofi and Topadur. Patent issued “mir-29 for the treatment of systemic sclerosis” (US8247389, EP2331143). RA has a consultancy relationship with and/or has received research funding from the following companies: Bristol Myers-Squibb, Pfizer, Genentech, Octapharma, CSL Behring, Mallinckrodt, AstraZeneca, Corbus, Kezar, Abbvie, Janssen, Kyverna Alexion, Argenx, Q32, EMD-Serono, Boehringer Ingelheim, Roivant, Merck, Galapagos, Actigraph, Scipher, Horizon Therepeutics, Teva, Beigene, ANI Pharmaceuticals, Biogen, Nuvig, Capella Bioscience, and CabalettaBio. Rest of the authors have no conflict of interest relevant to this manuscript.
: Ethical approval was obtained from the Institutional Ethics Committee of Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014.